MakroCare and ADDS Sign Exclusive Partnership for Safety Services

Share Article

MakroCare and ADDS sign exclusive partnership for Drug Safety and Pharmacovigilance services; These include QPPV, Case Processing, Call Center, PSUR writing, Medical review, Literature search and other safety related services.

Integrated global drug safety and pharmacovigilance services with Europe/USA/India business model

MakroCare is one of the fastest growing international CROs and a leader in providing clinical and medical services at the international level. Advanced Drug Development Services (ADDS) is a European CRO into advanced process of drugs and medical devices development, situated in France.

These two companies announced this November the signing of an exclusive partnership agreement for Pharmacovigilance and Drug safety services. This partnership allows both the companies to offer their wide range of Clinical, Medical and Safety services to pharmaceutical, biotechnology, and medical devices companies in key territories -USA/Europe/Asia/Africa.

Both the Companies will operate in key strategic areas of practice in the said regions, allowing each other an opportunity to offer their best and cost effective services to their existing and potential clients, leading to a better business outcome as well as successful development.

About Makrocare:
MakroCare, a global clinical services firm, provides clinical research support to pharmaceutical, biotechnology, and medical devices industries. The company offers site selection, patient recruitment, project and clinical data management, clinical monitoring, medical writing, PMS/Pharmacovigilance, biometrics, call centre service, regulatory assistance, and quality assurance. MakroCare has offices in USA (New Jersey, Illinois, Pennsylvania, and California), India (Hyderabad, Mumbai, Bengaluru and New Delhi), Japan (Tokyo), and Europe (Frankfurt).

About ADDS:
Advanced Drug Development Services SAS (ADDS) S is a European Contract Research Organisation (CRO), which provides full coverage of Phase II to IV clinical studies for drugs and medical devices in Europe as well as complete Pharmacovigilance and Risk Management services: including complete outsourcing of Pharmacovigilance department, European Qualified Person for Pharmacovigilance, Eudravigilance certification, safety data base and call centre.

For futher details, contact:
001-973-481-0100
91 40 44346666

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Media Manager
Visit website